Inventor · disambiguated record
Mark Manning
Also filed as: MANNING MARK · MANNING MARK C · MANNING MARK CORNELL
92 granted patents·32 pending applications·2,010 citations·filing 1978–2025
99Inventor score
Files withCOHERUS BIOSCIENCES INC74SHIRE VIROPHARMA INC7KINIKSA PHARMACEUTICALS LTD5UNIV TECHNOLOGY CORP5LEVO THERAPEUTICS INC4
Top patents by PatentIndex Score
124 records- 0198US10716852B2Stable aqueous formulations of adalimumabCOHERUS BIOSCIENCES INC·Filed 2018·Granted Jul 21, 2020·10 cites·22 claims
- 0298US10155039B2Stable aqueous formulations of adalimumabCOHERUS BIOSCIENCES INC·Filed 2017·Granted Dec 18, 2018·21 cites·12 claims
- 0398US9861695B2Stable aqueous formulations of adalimumabCOHERUS BIOSCIENCES INC·Filed 2016·Granted Jan 9, 2018·31 cites·25 claims
- 0498US9808525B2Stable aqueous formulations of adalimumabCOHERUS BIOSCIENCES INC·Filed 2015·Granted Nov 7, 2017·24 cites·11 claims
- 0598US9789185B2Stable aqueous formulations of adalimumabCOHERUS BIOSCIENCES INC·Filed 2016·Granted Oct 17, 2017·23 cites·27 claims
- 0698US9782480B2Stable aqueous formulations of adalimumabCOHERUS BIOSCIENCES INC·Filed 2016·Granted Oct 10, 2017·25 cites·10 claims
- 0798US9782479B2Stable aqueous formulations of adalimumabCOHERUS BIOSCIENCES INC·Filed 2015·Granted Oct 10, 2017·23 cites·20 claims
- 0898US9770507B2Stable aqueous formulations of adalimumabCOHERUS BIOSCIENCES INC·Filed 2016·Granted Sep 26, 2017·25 cites·8 claims
- 0998US9757454B2Stable aqueous formulations of adalimumabCOHERUS BIOSCIENCES INC·Filed 2016·Granted Sep 12, 2017·23 cites·29 claims
- 1098US9737600B2Stable aqueous formulations of adalimumabCOHERUS BIOSCIENCES INC·Filed 2016·Granted Aug 22, 2017·25 cites·9 claims
- 1198US9731008B2Stable aqueous formulations of adalimumabCOHERUS BIOSCIENCES INC·Filed 2016·Granted Aug 15, 2017·26 cites·20 claims
- 1298US9731009B2Stable aqueous formulations of adalimumabCOHERUS BIOSCIENCES INC·Filed 2016·Granted Aug 15, 2017·25 cites·8 claims
- 1398US9724415B2Stable aqueous formulations of adalimumabCOHERUS BIOSCIENCES INC·Filed 2016·Granted Aug 8, 2017·25 cites·10 claims
- 1498US9724414B2Stable aqueous formulations of adalimumabCOHERUS BIOSCIENCES INC·Filed 2015·Granted Aug 8, 2017·23 cites·25 claims
- 1598US9707293B2Stable aqueous formulations of adalimumabCOHERUS BIOSCIENCES INC·Filed 2016·Granted Jul 18, 2017·25 cites·15 claims
- 1698US9682145B2Stable aqueous formulations of adalimumabCOHERUS BIOSCIENCES INC·Filed 2016·Granted Jun 20, 2017·23 cites·29 claims
- 1798US9382317B2Stable aqueous formulations of adalimumabCOHERUS BIOSCIENCES INC·Filed 2015·Granted Jul 5, 2016·55 cites·10 claims
- 1898US9346880B2Stable aqueous formulations of adalimumabCOHERUS BIOSCIENCES INC·Filed 2015·Granted May 24, 2016·44 cites·20 claims
- 1998US9340611B2Stable aqueous formulations of adalimumabCOHERUS BIOSCIENCES INC·Filed 2015·Granted May 17, 2016·43 cites·12 claims
- 2098US9340612B2Stable aqueous formulations of adalimumabCOHERUS BIOSCIENCES INC·Filed 2015·Granted May 17, 2016·42 cites·20 claims
- 2198US6613358B2Sustained-release composition including amorphous polymerFiled 2001·Granted Sep 2, 2003·471 cites·48 claims
- 2297US10207000B2Stable aqueous formulations of adalimumabCOHERUS BIOSCIENCES INC·Filed 2017·Granted Feb 19, 2019·16 cites·11 claims
- 2397US10195275B2Stable aqueous formulations of adalimumabCOHERUS BIOSCIENCES INC·Filed 2018·Granted Feb 5, 2019·15 cites·25 claims
- 2497US10159733B2Stable aqueous formulations of adalimumabCOHERUS BIOSCIENCES INC·Filed 2017·Granted Dec 25, 2018·15 cites·9 claims
- 2597US10159732B2Stable aqueous formulations of adalimumabCOHERUS BIOSCIENCES INC·Filed 2017·Granted Dec 25, 2018·15 cites·13 claims
- 2696US10722579B2Stable aqueous formulations of adalimumabCOHERUS BIOSCIENCES INC·Filed 2018·Granted Jul 28, 2020·5 cites·22 claims
- 2796US10716853B2Stable aqueous formulations of adalimumabCOHERUS BIOSCIENCES INC·Filed 2018·Granted Jul 21, 2020·5 cites·22 claims
- 2896US10716854B2Stable aqueous formulations of adalimumabCOHERUS BIOSCIENCES INC·Filed 2018·Granted Jul 21, 2020·5 cites·22 claims
- 2996US5981474ASolubilization of pharmaceutical substances in an organic solvent and preparation of pharmaceutical powders using the sameUNIV TECHNOLOGY CORP·Filed 1998·Granted Nov 9, 1999·211 cites·21 claims
- 3096US5770559ASolubilization of pharmaceutical substances in an organic solvent and preparation of pharmaceutical powders using the sameUNIV COLORADO·Filed 1995·Granted Jun 23, 1998·218 cites·31 claims
- 3195US9943601B2Etanercept formulations stabilized with combinations of sugars and polyolsCOHERUS BIOSCIENCES INC·Filed 2016·Granted Apr 17, 2018·12 cites·8 claims
- 3294US10799585B2Stable aqueous formulations of adalimumabCOHERUS BIOSCIENCES INC·Filed 2018·Granted Oct 13, 2020·2 cites·16 claims
- 3394US10772960B2Stable aqueous formulations of adalimumabCOHERUS BIOSCIENCES INC·Filed 2018·Granted Sep 15, 2020·2 cites·16 claims
- 3494US10772959B2Stable aqueous formulations of adalimumabCOHERUS BIOSCIENCES INC·Filed 2018·Granted Sep 15, 2020·2 cites·16 claims
- 3594US10688183B2Stable aqueous formulations of adalimumabCOHERUS BIOSCIENCES INC·Filed 2018·Granted Jun 23, 2020·2 cites·16 claims
- 3694US10080788B2C1-INH compositions and methods for the prevention and treatment of disorders associated with C1 esterase inhibitor deficiencySHIRE VIROPHARMA INC·Filed 2017·Granted Sep 25, 2018·4 cites·30 claims
- 3794US9770510B2Etanercept formulations stabilized with xylitolCOHERUS BIOSCIENCES INC·Filed 2016·Granted Sep 26, 2017·9 cites·18 claims
- 3894US9616111B2C1-INH compositions and methods for the prevention and treatment of disorders associated with C1 esterase inhibitor deficiencySHIRE VIROPHARMA INC·Filed 2015·Granted Apr 11, 2017·12 cites·18 claims
- 3994US9393305B2Etanercept formulations stabilized with xylitolCOHERUS BIOSCIENCES INC·Filed 2012·Granted Jul 19, 2016·13 cites·3 claims
- 4094US9302002B2Etanercept formulations stabilized with combinations of sugars and polyolsCOHERUS BIOSCIENCES INC·Filed 2012·Granted Apr 5, 2016·16 cites·8 claims
- 4193US10786566B2Stable aqueous formulations of adalimumabCOHERUS BIOSCIENCES INC·Filed 2017·Granted Sep 29, 2020·2 cites·17 claims
- 4293US10780163B2Stable aqueous formulations of adalimumabCOHERUS BIOSCIENCES INC·Filed 2017·Granted Sep 22, 2020·2 cites·29 claims
- 4392US10485869B2Etanercept formulations stabilized with meglumineCOHERUS BIOSCIENCES INC·Filed 2012·Granted Nov 26, 2019·7 cites·7 claims
- 4492US10376588B2Etanercept formulations stabilized with combinations of sugars and polyolsCOHERUS BIOSCIENCES INC·Filed 2018·Granted Aug 13, 2019·5 cites·13 claims
- 4592US10213508B2Etanercept formulations stabilized with xylitolCOHERUS BIOSCIENCES INC·Filed 2017·Granted Feb 26, 2019·5 cites·24 claims
- 4691US10293049B2Etanercept formulations stabilized with amino acidsCOHERUS BIOSCIENCES INC·Filed 2012·Granted May 21, 2019·8 cites·15 claims
- 4791US10286071B2Syringe containing stable aqueous formulations of adalimumabCOHERUS BIOSCIENCES INC·Filed 2017·Granted May 14, 2019·3 cites·20 claims
- 4891US10286072B2Methods of manufacturing stable aqueous formulations of adalimumabCOHERUS BIOSCIENCES INC·Filed 2017·Granted May 14, 2019·3 cites·20 claims
- 4991US10201595B2C1-INH compositions and methods for the prevention and treatment of disorders associated with C1 esterase inhibitor deficiencySHIRE VIROPHARMA INC·Filed 2017·Granted Feb 12, 2019·2 cites·30 claims
- 5091US10130690B2C1-INH compositions and methods for the prevention and treatment of disorders associated with C1 esterase inhibitor deficiencySHIRE VIROPHARMA INC·Filed 2017·Granted Nov 20, 2018·2 cites·29 claims
Showing the top 50 of 124 patent records by PatentIndex Score.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →